Metabolic Associated Steatotic Liver Disease
Metabolic·MeSH: Non-alcoholic Fatty Liver Disease
1 drug in development·1 company·1 clinical trial
Drug Pipeline by Phase
Phase 2(1)
| Drug | Company |
|---|---|
| tesamorelin | IO Biotech, Inc. (IOBT) |
Frequently asked questions
How many drugs are in development for Metabolic Associated Steatotic Liver Disease?
BioSniper tracks 1 drug in development for Metabolic Associated Steatotic Liver Disease across 1 company.
How many clinical trials target Metabolic Associated Steatotic Liver Disease?
There are 1 clinical trial targeting Metabolic Associated Steatotic Liver Disease tracked by BioSniper.
Deep-dive into Metabolic Associated Steatotic Liver Disease
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis